William E. Boden, MD, reports that high-dose, extended-release niacin does not reduce the risk of cardiovascular events in patients with bad cholesterol (LDL) that is well controlled by statins.
Anne B. Curtis, MD, is the Buffalo area spokesperson for AF Awareness Month, the Heart Rhythm Society’s national campaign to raise awareness about atrial fibrillation.
Since being named dean of the UB School of Medicine and Biomedical Sciences, Michael E. Cain, MD, has appointed six new chairs and high-level physician-scientists.
The National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) has stopped the AIM-HIGH clinical research trial 18 months earlier than planned due to lack of efficacy in reducing cardiovascular events.